6,000 Shares in CVS Health Corporation $CVS Acquired by Reliant Investment Partners LLC

Reliant Investment Partners LLC acquired a new stake in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 6,000 shares of the pharmacy operator’s stock, valued at approximately $621,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Elevation Wealth Partners LLC increased its stake in shares of CVS Health by 41.8% in the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 105 shares during the period. Apella Capital LLC boosted its position in CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock valued at $724,000 after buying an additional 117 shares during the period. CYBER HORNET ETFs LLC grew its holdings in CVS Health by 4.1% in the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 134 shares during the last quarter. Northwestern Mutual Investment Management Company LLC increased its position in shares of CVS Health by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 40,560 shares of the pharmacy operator’s stock valued at $3,219,000 after acquiring an additional 136 shares during the period. Finally, CoreCap Advisors LLC raised its stake in shares of CVS Health by 4.2% during the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator’s stock valued at $360,000 after acquiring an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on CVS shares. Wells Fargo & Company increased their target price on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Robert W. Baird set a $107.00 price objective on CVS Health in a report on Thursday, August 6th. UBS Group lifted their price objective on CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Finally, Cantor Fitzgerald boosted their target price on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Trading Up 0.2%

Shares of CVS opened at $93.83 on Friday. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $102.19 and its 200-day moving average price is $88.83. The firm has a market capitalization of $120.01 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 0.89 and a beta of 0.61.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the prior year, the firm earned $1.81 earnings per share. CVS Health’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.